Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Caleres reported its second quarter 2024 on September 12, 2024. The Company reported sales below analyst expectations and also lowered its yearly guidance. Following on this news, shares of Caleres fell over 19% in intraday trading on the same day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |
| GSK | GSK plc | April 07, 2025 | Join |
| NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
| MRK | Merck & Co., Inc. | April 14, 2025 | Join |
| VG | Venture Global, Inc. | April 18, 2025 | Join |
| STZ | Constellation Brands, Inc. | April 21, 2025 | Join |
| SWKS | Skyworks Solutions, Inc. | May 05, 2025 | Join |